| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.012 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0079 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.0089 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |